Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ZIOP ZIOPHARM Oncology, Inc. daily Stock Chart
ZIOP [NASD]
ZIOPHARM Oncology, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.54 Insider Own1.70% Shs Outstand154.54M Perf Week8.82%
Market Cap400.26M Forward P/E- EPS next Y-0.32 Insider Trans0.00% Shs Float154.54M Perf Month11.64%
Income-75.60M PEG- EPS next Q-0.11 Inst Own44.90% Short Float26.28% Perf Quarter-4.07%
Sales1.70M P/S235.45 EPS this Y59.50% Inst Trans25.79% Short Ratio20.13 Perf Half Y1.17%
Book/sh-1.11 P/B- EPS next Y37.30% ROA-89.90% Target Price4.50 Perf Year-34.26%
Cash/sh0.21 P/C12.63 EPS next 5Y- ROE58.60% 52W Range1.56 - 5.00 Perf YTD38.50%
Dividend- P/FCF- EPS past 5Y15.30% ROI55.30% 52W High-48.20% Beta2.47
Dividend %- Quick Ratio0.80 Sales past 5Y51.50% Gross Margin- 52W Low66.03% ATR0.17
Employees46 Current Ratio0.80 Sales Q/Q- Oper. Margin- RSI (14)59.73 Volatility6.63% 7.63%
OptionableYes Debt/Eq- EPS Q/Q-5.60% Profit Margin- Rel Volume0.70 Prev Close2.57
ShortableYes LT Debt/Eq- EarningsFeb 28 AMC Payout- Avg Volume2.02M Price2.59
Recom2.80 SMA2014.58% SMA509.50% SMA200-13.04% Volume1,411,182 Change0.78%
Nov-15-18Upgrade Raymond James Mkt Perform → Outperform
Jun-18-18Downgrade JP Morgan Neutral → Underweight
Jun-01-17Initiated H.C. Wainwright Buy $9.50
Aug-10-16Upgrade Wells Fargo Underperform → Market Perform
Jul-19-16Reiterated Mizuho Neutral $7 → $5
Jun-02-16Initiated Raymond James Mkt Perform
May-11-16Reiterated Mizuho Neutral $6 → $7
Jan-25-16Reiterated Mizuho Neutral $10 → $6
Dec-04-15Initiated Wells Fargo Underperform
Jun-10-15Reiterated Mizuho Neutral $14 → $10
Mar-10-15Downgrade Mizuho Buy → Neutral $14
Mar-02-15Reiterated Mizuho Buy $11 → $14
Mar-20-14Initiated Mizuho Buy $11
Apr-02-12Reiterated Griffin Securities Buy $9 → $12
Mar-26-12Initiated Canaccord Genuity Buy $9
Dec-15-11Initiated Global Hunter Securities Buy $9
Nov-22-11Initiated Collins Stewart Buy $9
Feb-23-11Initiated Barclays Capital Overweight $9
Feb-08-11Reiterated Dawson James Buy $6 → $8
Aug-02-10Initiated Dawson James Buy $6
Feb-14-19 08:30AM  Recent Analysis Shows Lattice Semiconductor, ZIOPHARM Oncology, Ferro, SYNNEX, AxoGen, and Twin Disc Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-13-19 06:49AM  Is ZIOPHARM Oncology, Inc.s (NASDAQ:ZIOP) CEO Paid At A Competitive Rate? Simply Wall St.
Feb-11-19 07:45AM  Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial GlobeNewswire
Feb-01-19 07:30AM  The Unknown Biotech Play that Could Deliver 400% Returns, or Much More ACCESSWIRE
Jan-21-19 09:00AM  Biotech Stocks on the Move ACCESSWIRE
Jan-07-19 04:01PM  Ziopharm Oncology Posts Letter to Stockholders GlobeNewswire
Dec-28-18 08:52AM  Ziopharm Oncology (ZIOP) in Focus: Stock Moves 6.2% Higher Zacks
Dec-27-18 01:16PM  Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets GlobeNewswire +6.21%
12:45PM  4 Healthcare Stocks That Could Test December Highs ACCESSWIRE
Dec-23-18 09:26PM  Do Hedge Funds Love ZIOPHARM Oncology Inc. (ZIOP)? Insider Monkey
Dec-21-18 09:15AM  Is the Options Market Predicting a Spike in Ziopharm Oncology (ZIOP) Stock? Zacks -7.44%
08:00AM  Ziopharm Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-19-18 06:59AM  Ziopharm Oncology and TriArm Therapeutics Establish Joint Venture to Develop and Commercialize Sleeping Beauty CAR T in China, Taiwan and Korea GlobeNewswire -5.35%
Dec-14-18 07:47AM  The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch Benzinga
Dec-13-18 04:15PM  Ziopharm Oncology Promotes Dr. David Mauney to President GlobeNewswire
Dec-04-18 08:17PM  Edited Transcript of ZIOP earnings conference call or presentation 12-Nov-18 1:00pm GMT Thomson Reuters StreetEvents -5.69%
Dec-03-18 07:25AM  Market Trends Toward New Normal in Zillow Group, YRC Worldwide, The Home Depot, UROGEN PHARMA, ZIOPHARM Oncology, and Cinedigm Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-29-18 08:40AM  Are Options Traders Betting on a Big Move in ZIOPHARM Oncology (ZIOP) Stock? Zacks -9.12%
Nov-16-18 02:30PM  Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology GlobeNewswire
08:08AM  The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal Benzinga
Nov-14-18 09:15AM  Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges Zacks
Nov-13-18 02:10PM  Ziopharm Oncology (ZIOP) Reports Q3 Loss, Lags Revenue Estimates Zacks +16.38%
Nov-12-18 07:01AM  Ziopharm Oncology to Host Conference Call Today at 8 a.m. GlobeNewswire -7.57%
07:00AM  Ziopharm Oncology Announces Immuno-oncology Clinical Supply Agreement with Regeneron to Evaluate Combination Therapy for Patients with Brain Cancer GlobeNewswire
06:58AM  Ziopharm Oncology Announces $50 Million Private Placement GlobeNewswire
Nov-11-18 10:01AM  Is ZIOPHARM Oncology Inc (NASDAQ:ZIOP) A Financially Sound Company? Simply Wall St.
Nov-09-18 02:08PM  Intrexon (XON) Reports Narrower-Than-Expected Loss in Q3 Zacks
Nov-08-18 04:01PM  Ziopharm Oncology Third Quarter 2018 Financial Results Conference Call Rescheduled to Nov. 12 GlobeNewswire
Nov-07-18 04:02PM  Ziopharm Oncology to Present at the Stifel 2018 Healthcare Conference on Nov. 14 GlobeNewswire +8.33%
Nov-05-18 07:00AM  Ziopharm Oncology to Present Update on Controlled IL-12 Brain Cancer Trial at Annual Meeting of the Society for Neuro-Oncology on Nov. 16 GlobeNewswire
Oct-31-18 04:30PM  Ziopharm Oncology to Announce Third Quarter 2018 Financial Results, Host Conference Call Nov. 8 GlobeNewswire
Oct-29-18 10:31AM  Ziopharm Oncology (ZIOP) Q3 Earnings Preview: What's Shaping Up? Zacks -8.37%
Oct-26-18 08:49AM  Implied Volatility Surging for ZIOPHARM Oncology (ZIOP) Stock Options Zacks
Oct-24-18 07:25AM  Report: Developing Opportunities within Univar, Aqua America, Chimerix, Superior Energy Services, TechTarget, and ZIOPHARM Oncology Future Expectations, Projections Moving into 2018 GlobeNewswire -6.82%
Oct-16-18 04:01PM  Ziopharm Oncology Announces Changes to Board of Directors and Management Team GlobeNewswire +8.47%
Oct-09-18 07:00AM  Ziopharm and Precigen Redefine Relationships, Announce New License Agreement GlobeNewswire
Sep-25-18 07:30AM  Ziopharm Oncology to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-20-18 08:36AM  Should You Have ZIOPHARM Oncology Incs (NASDAQ:ZIOP) In Your Portfolio? Simply Wall St. +7.02%
Sep-19-18 08:55AM  Is the Options Market Predicting a Spike in ZIOPHARM Oncology (ZIOP) Stock? Zacks
Sep-04-18 09:15AM  CORRECTING and REPLACING -- Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors GlobeNewswire
07:30AM  Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors GlobeNewswire
Aug-22-18 07:50PM  Edited Transcript of ZIOP earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents -7.33%
Aug-14-18 07:57AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ziopharm Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire -5.90%
Aug-11-18 07:03AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Aug-09-18 03:36PM  Why Ziopharm Oncology Is Soaring 14% Today Motley Fool +10.76%
Aug-08-18 07:35PM  Ziopharm Oncology (ZIOP) Reports Q2 Loss, Lags Revenue Estimates Zacks -5.64%
06:32PM  Ziopharm: 2Q Earnings Snapshot Associated Press
04:01PM  Ziopharm Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  ZIOPHARM Oncology, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-18 04:00PM  Why Ziopharm Oncology Stock Zoomed 16.8% Higher Today Motley Fool +17.70%
07:30AM  Ziopharm Oncology Announces Changes to its Board of Directors GlobeNewswire
Jul-31-18 07:45AM  Ziopharm Oncology to Announce Second Quarter 2018 Financial Results, Host Conference Call Aug. 8 GlobeNewswire +6.15%
Jul-30-18 07:20AM  Breakfast Technical Briefing on ZIOPHARM Oncology and Three Other Additional Biotech Stocks ACCESSWIRE
Jul-26-18 12:05PM  Ziopharm Oncology Board Responds to Recent Stock Price Decline GlobeNewswire
Jul-19-18 08:24AM  Why Ziopharm Oncology Stock Fell by 27% Halfway Through 2018 Motley Fool
Jul-02-18 07:25AM  Initiating Free Research Reports on ZIOPHARM Oncology and Three Other Biotech Equities ACCESSWIRE
Jun-29-18 08:17AM  Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics Motley Fool
07:55AM  Investor Expectations to Drive Momentum within ZIOPHARM Oncology, MedEquities Realty Trust, Argan, Churchill Downs, Tyson Foods, and Acadia Realty Trust Discovering Underlying Factors of Influence GlobeNewswire
Jun-28-18 04:01PM  Ziopharm Oncology Enrolls First Patient in Phase 1 Trial Evaluating Combination Therapy of Controlled IL-12 and OPDIVO® GlobeNewswire
Jun-20-18 08:32AM  Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash Zacks +5.88%
Jun-19-18 08:00AM  Todays Research Reports on Stocks to Watch: Arrowhead Pharmaceuticals and ZIOPHARM Oncology ACCESSWIRE
Jun-18-18 04:10PM  Why Ziopharm Oncology is Crashing by 17.7% Today Motley Fool -18.37%
07:43AM  Ziopharm Oncology shares slide 7% premarket after FDA places clinical hold on cancer trial MarketWatch
07:30AM  Ziopharm Oncology Reports on Status of Investigational New Drug Application for Phase 1 Trial to Evaluate CD19-targeted CAR T Therapy GlobeNewswire
Jun-17-18 07:17AM  Is Ziopharm Oncology Inc. a Buy? Motley Fool
Jun-09-18 02:01PM  Why ZIOPHARM Oncology, Inc. Stock Broke Out in May Motley Fool
Jun-05-18 07:40AM  Complimentary Technical Snapshots on Viking Therapeutics and Three More Biotech Stocks ACCESSWIRE
Jun-04-18 07:56AM  Ziopharm Oncology Presents Clinical Data Demonstrating Anti-tumor Immune Response of Controlled IL-12 Platform in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire -8.59%
May-31-18 08:20AM  Today's Research Reports on Trending Tickers: Sangamo Therapeutics and ZIOPHARM Oncology ACCESSWIRE
May-23-18 01:53AM  Edited Transcript of ZIOP earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-16-18 05:00PM  Ziopharm Oncology to Present Data from Clinical Studies of Controlled IL-12 in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
08:00AM  New Research: Key Drivers of Growth for root9B Holdings Inc., Comfort Systems, SS&C Technologies, ZIOPHARM Oncology, L Brands, and QEP Resources Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
May-12-18 07:16AM  Better Buy: Ziopharm Oncology, Inc. vs. bluebird bio Inc. Motley Fool
May-11-18 04:00PM  Here's What's Causing Intrexon to Tumble 20% Today Motley Fool
May-10-18 05:34PM  Ziopharm: 1Q Earnings Snapshot Associated Press
04:01PM  Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-02-18 07:57AM  Ziopharm Oncology to Announce First Quarter 2018 Financial Results, Host Conference Call May 10 GlobeNewswire
Apr-03-18 02:45PM  Is Ziopharm Oncology, Inc. a Buy? Motley Fool +8.31%
Mar-09-18 07:45AM  New Research Coverage Highlights Great Western, Acadia Realty Trust, Interpace Diagnostics Group, Abercrombie & Fitch, United Rentals, and ZIOPHARM Oncology Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire +5.34%
Mar-05-18 06:15PM  Edited Transcript of ZIOP earnings conference call or presentation 1-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-02-18 12:32PM  Intrexon (XON) Q4 Loss Narrower Than Expected, Revenues Beat Zacks +11.60%
Mar-01-18 04:59PM  Ziopharm reports 4Q loss Associated Press
04:01PM  Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update GlobeNewswire
12:00PM  ZIOPHARM Oncology, Inc. to Host Earnings Call ACCESSWIRE
Feb-14-18 07:30AM  Wired News Ziopharm Oncology Presents Data on Rapid Production of CAR T Cells at Keystone Symposia ACCESSWIRE
Feb-13-18 07:15AM  Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1 GlobeNewswire
Feb-12-18 07:00AM  Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond GlobeNewswire
Feb-06-18 12:14PM  Ziopharm stock rallies after company says nothing to see here, folks MarketWatch +15.90%
08:55AM  Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance GlobeNewswire
Jan-24-18 02:35PM  Behind Celgenes Strategy in the Juno Therapeutics Acquisition Market Realist -5.93%
Jan-23-18 08:10AM  Todays Research Reports on Trending Tickers: Spectrum Pharmaceuticals and ZIOPHARM Oncology ACCESSWIRE
Jan-22-18 06:00PM  Did ZIOPHARM Oncology Incs (NASDAQ:ZIOP) Earnings Growth Outperform The Industry? Simply Wall St. +20.09%
Jan-17-18 07:30AM  Could Little Known Orgenesis (ORGS) Become A Dominant Player in The Multi Billion Dollar Cell Therapy Market? ACCESSWIRE
Jan-11-18 07:30AM  Blog Exposure - ZIOPHARM Updated on Key Clinical Programs and Corporate Development Activities ACCESSWIRE
Jan-09-18 07:00AM  Ziopharm Oncology Provides Update on Standout Technologies during the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 12:46PM  ETFs with exposure to ZIOPHARM Oncology, Inc. : December 28, 2017 Capital Cube
Dec-27-17 08:50AM  ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-21-17 04:05PM  ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Nov-30-17 09:19AM  Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc. Motley Fool
Nov-28-17 08:25AM  Detailed Research: Economic Perspectives on eBay, Maxwell Technologies, The Priceline Group, Allscripts Healthcare Solutions, Ziopharm Oncology, and H&R Block What Drives Growth in Today's Competitive Landscape GlobeNewswire
ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown antigens. The company develops two immuno-oncology platform technologies, including Controlled IL-12, which delivers interleukin 12 or IL-12, a master regular of the immune system, in a controlled and safe manner to focus the patient's immune system to cancer; and Sleeping Beauty (SB), which is based on the genetic engineering of T-cells using the (SB) system to rapidly reprogram T-cells outside of the body for infusion. Its lead gene therapy product candidate is Ad-RTS-hIL-12 plus veledimex, which is in Phase I clinical trial, a gene therapy product candidate to treat patients with recurrent glioblastoma. The company is also developing chimeric antigen receptor (CAR) T-cell and T-cell receptor T-cell therapies. ZIOPHARM Oncology, Inc. has collaboration agreements with Precigen, Inc., MD Anderson Cancer Center, the National Cancer Institute, and Ares Trading S.A. The company is headquartered in Boston, Massachusetts.
open in yahoo | open in reuters | open in google